Antiretroviral Therapy, Highly Active
-
Subject Areas on Research
-
"It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.
-
A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults.
-
A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa.
-
A plausible causal link between antiretroviral therapy and increased blood pressure in a sub-Saharan African setting: A propensity score-matched analysis.
-
A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period.
-
AIDS is your business.
-
Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.
-
Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.
-
Adherence to HAART among patients with HIV: breakthroughs and barriers.
-
Adherence to antiretroviral therapy among HIV-infected children receiving care at Kilimanjaro Christian Medical Centre (KCMC), Northern Tanzania: A cross- sectional analytical study.
-
Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences.
-
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.
-
Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.
-
An information criterion for marginal structural models.
-
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.
-
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection.
-
Antiretroviral medications: adverse effects on the kidney.
-
Antiretroviral therapy and the kidney.
-
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.
-
Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.
-
Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.
-
Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents.
-
Antiretroviral therapy where resources are limited.
-
Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
-
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
-
Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
-
Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.
-
Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.
-
Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the Southeastern United States.
-
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.
-
Building resilience: a mental health intervention for Tanzanian youth living with HIV.
-
CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.
-
Causes of death on antiretroviral therapy: a post-mortem study from South Africa.
-
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.
-
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
-
Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP).
-
Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.
-
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.
-
Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
-
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.
-
Complications of human immunodeficiency virus therapy.
-
Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.
-
Cost-effectiveness of HIV screening in patients older than 55 years of age.
-
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
-
Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.
-
Crosstalk in competing endogenous RNA networks reveals new circular RNAs involved in the pathogenesis of early HIV infection.
-
Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
-
Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics.
-
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
-
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
-
Detection of minor drug-resistant populations by parallel allele-specific sequencing.
-
Does access to health care impact survival time after diagnosis of AIDS?
-
Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.
-
Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China.
-
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.
-
Early detection: the next steps.
-
Economic evaluation of ART in resource-limited countries.
-
Effect of HAART on Brain Organization and Function in HIV-Negative Subjects.
-
Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
-
Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
-
Effect of pregnancy and human immunodeficiency virus infection on intracellular interleukin-2 production patterns.
-
Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.
-
Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee.
-
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
-
Effects of Nurse-Delivered Cognitive Behavioral Intervention on Depression and Anxiety for Persons Living With HIV in China: A Clinical Controlled Trial.
-
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
-
Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
-
Epidemic impacts of a community empowerment intervention for HIV prevention among female sex workers in generalized and concentrated epidemics.
-
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.
-
Estimation and prediction with HIV-treatment interruption data.
-
Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.
-
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria.
-
Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy.
-
FDG PET/CT in patients with HIV.
-
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
-
Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.
-
Frailty and Neurocognitive Impairment: Impacts on Quality of Life in HIV.
-
Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse.
-
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.
-
Global dimensions of the AIDS epidemic: implications for prevention and care.
-
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
-
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.
-
HIV and older adults: clinical outcomes in the era of HAART.
-
HIV antibodies for treatment of HIV infection.
-
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
-
HIV disorders of the brain: pathology and pathogenesis.
-
HIV immune reconstitution syndrome in sub-Saharan Africa.
-
HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
-
HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS.
-
HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania.
-
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
-
HIV-1 Drug Resistance and Virologic Outcomes Among Tanzanian Youth Living With HIV.
-
HIV-1 and HIV-Associated Nephropathy 25 Years Later.
-
HIV-1 dynamics in haemodialysis patients.
-
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
-
High prevalence of PI resistance in patients failing second-line ART in Vietnam.
-
High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?
-
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease.
-
Host APOL1 genotype is independently associated with proteinuria in HIV infection.
-
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.
-
Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
-
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.
-
Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
-
Immune reconstitution inflammatory syndrome involving the central nervous system in a patient with HIV infection: a case report and review of literature.
-
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy.
-
Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy.
-
Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System.
-
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.
-
Impact of genotypic resistance testing on physician selection of antiretroviral therapy.
-
Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study.
-
Improvement of HAART in Brazil, 1998-2008: a nationwide assessment of survival times after AIDS diagnosis among men who have sex with men.
-
In or out? Methodological considerations for including and excluding findings from a meta-analysis of predictors of antiretroviral adherence in HIV-positive women.
-
Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care.
-
Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil.
-
Interactions between highly active antiretroviral therapy and over-the-counter agents: a cautionary note.
-
Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
-
Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.
-
Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.
-
Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?
-
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
-
Kidney transplantation in HIV-infected patients.
-
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.
-
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.
-
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
-
Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.
-
Maximizing the benefits of antiretroviral therapy for key affected populations.
-
Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
-
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
-
Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.
-
Minimizing the Risk of Perinatal Human Immunodeficiency Virus Transmission.
-
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.
-
Mortality and loss to follow-up among HAART initiators in rural South Africa.
-
Mortality under plausible interventions on antiretroviral treatment and depression in HIV-infected women: an application of the parametric g-formula.
-
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.
-
Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.
-
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection.
-
Nursing Science Throughout the Epidemic: Lessons Learned and the Way Forward.
-
Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study.
-
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.
-
Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy.
-
Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.
-
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.
-
Pharmacological considerations in human immunodeficiency virus-infected adults in the intensive care unit.
-
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death.
-
Physical exercise is associated with less neurocognitive impairment among HIV-infected adults.
-
Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.
-
Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.
-
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.
-
Predictors of glycaemic control among HIV-positive veterans with diabetes.
-
Prevalence and correlates of probable depression diagnosis and suicidal ideation among patients receiving HIV care in Lilongwe, Malawi.
-
Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon.
-
Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.
-
Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.
-
Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.
-
Progress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.
-
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
-
Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.
-
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
-
Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.
-
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.
-
Recent developments regarding human immunodeficiency virus infection and stroke.
-
Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer.
-
Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy.
-
Religion and HIV in Tanzania: influence of religious beliefs on HIV stigma, disclosure, and treatment attitudes.
-
Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV?
-
Revisiting Successful Aging With HIV Through a Revised Biopsychosocial Model: An Update of the Literature.
-
Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
-
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
-
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals.
-
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy.
-
Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting.
-
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
-
Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.
-
Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.
-
Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.
-
Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.
-
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.
-
Skin infections in HIV-infected individuals in the era of HAART.
-
Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settings.
-
Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.
-
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.
-
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.
-
Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?
-
The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds.
-
The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
-
The global response to HIV in men who have sex with men.
-
The impact of highly active antiretroviral therapy on activities of daily living in HIV-infected adults in South Africa.
-
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.
-
The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study.
-
The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.
-
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
-
Thrombotic thrombocytopenic purpura during immune reconstitution.
-
Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.
-
Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.
-
Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.
-
Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months.
-
Transplantation in the HIV+ patient.
-
Treatment and CD4+ T cell count recovery among antiretroviral therapy-naive patients with HIV/AIDS.
-
Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.
-
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
-
Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.
-
Understanding the HIV Epidemic Among MSM in Baltimore: A Modeling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections.
-
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
-
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.
-
Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
-
Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual.
-
WHO's new HIV guidelines: opportunities and challenges.
-
WHO's new guidelines for antiretroviral treatment - Authors' reply.
-
Keywords of People
-
-
Barker, Piers Christopher Andrew,
Professor of Pediatrics,
Pediatrics, Cardiology
-
Ferrari, Guido,
Professor in Surgery,
Molecular Genetics and Microbiology
-
Klotman, Mary E,
R.J. Reynolds Distinguished Professor of Medicine,
School of Medicine
-
Weinhold, Kent James,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Integrative Immunobiology
-
Whetten, Kathryn,
Professor in the Sanford School of Public Policy,
School of Nursing